Neurobiology of Diabetic Neuropathy: Volume 50
- Hardback | 482 pages
- 156 x 232 x 26mm | 839.14g
- 14 Aug 2002
- Elsevier Science Publishing Co Inc
- Academic Press Inc
- San Diego, United States
Other books in this series
28 Aug 2017
29 Aug 2017
06 Aug 2014
29 Sep 2009
07 Feb 2006
26 Jan 2004
17 Nov 2011
25 Nov 2013
21 Dec 2011
28 Dec 2012
16 Sep 2014
28 Jul 2005
02 Aug 2011
30 Oct 2015
22 Apr 2016
Table of contents
How does glucose generate oxidative stress in Peripheral Nerve? Irina Obrosova.
Glycation in Diabetic Neuropathy: Characteristics, Consequences, Causes and Therapeutic Options, Paul Thornalley.
Protein Kinase C Changes in Diabetes -- Is the concept relevant to neuropathy? Joseph Eichberg.
Are MAP kinases glucose transducers for diabetic neuropathies? Tertia D. Purves and David R. Tomlinson.
Neurofilaments in Diabetic Neuropathy, Paul Fernyhough and Robert E. Schmidt.
Apoptosis in Diabetic Neuropathy, Aviva Tolkovsky.
Nerve and Ganglion Blood Flow in Diabetes: An Appraisal, Douglas W. Zochodne.
Potential Mechanisms of Neuropathic Pain in Diabetes Nigel A. Calcutt.
Changes in nerve conduction velocity - What Are Their Mechanisms and What Do They Mean?
Neuropathology and Pathogenesis of Diabetic Autonomic Neuropathy, Robert E. Schmidt.
The Role of the Schwann Cell in Diabetic Neuropathy, Luke Eckersley.
The Polyol Pathway and Diabetic Peripheral Neuropathy, Peter J. Oates.
Nerve Growth Factor for the Treatment of Diabetic Neuropathy: What went wrong, What went right and what does the future hold? Stuart C. Apfel.
ACE Inhibitors -- Are there Credible Mechanisms for Beneficial Effects in Diabetic Neuropathy? Rayaz Malik and David Tomlinson.
Clinical trials for drugs against diabetic neuropathy -- can we combine scientific needs with clinical and economic practicalities? Dan Ziegler and Dieter Luft.